Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Oesophageal cancer
Closed
Phase 3
This trial is looking at whether having pembrolizumab before and during is better than chemoradiotherapy only. It is for people with oesophageal cancer who aren’t having surgery.
Oesophageal cancer includes cancer where the oesophagus (food pipe) joins the stomach (the gastro oesophageal junction).
Recruitment start: 28 February 2020
Recruitment end: 1 March 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Wasat Mansoor
Merck Sharp & Dohme Ltd
Last reviewed: 04 Mar 2024
CRUK internal database number: 17541